期刊
JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS
卷 1, 期 3, 页码 118-125出版社
KARGER
DOI: 10.1159/000112459
关键词
Genetics; Polymorphisms; Myocardial infarction; Stroke; Insulin resistance
资金
- Heart and Stroke Foundation of Ontario Program [PRG-5967]
- Canadian Institutes of Health Research [MOP-79533]
- Heart and Stroke Foundation of Ontario [T-6018]
- Genome Canada through the Ontario Genornics Institute
The metabolic syndrome (MetS) is a commonly encountered cluster of clinical phenotypes, including central obesity, hypertension, hyperglycemia, and dyslipidemia. Identifying genetic determinants of MetS will lead to better understanding of its progression and pathogenesis. To further the knowledge of MetS it is important to not only study the candidate genes for each individual component but to also investigate patients with rare monogenic disorders who express a cluster of the phenotypes commonly observed in MetS, however defined. In addition, certain genetic variants have been observed to increase or decrease the risk of developing the entire syndrome. It is apparent that only through complete understanding of the gene-gene, gene-gender and gene-nutrition interactions underlying MetS, will it become possible to determine or minimize the principal complications, namely type 2 diabetes and cardiovascular disease. In this review, we focus on the current evidence for common gene polymorphisms that predispose to or protect from the development of MetS. Copyright (C) 2008 S, Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据